ArthroLense is developing augmented and mixed reality-based surgical navigation systems. The company’s initial products are designed for hip and knee replacement.
Instead of using touch screens and foot pedal controls, ArthroLense features “gestures and voice commands, an ideal configuration for busy surgeons, and particularly those operating at ambulatory surgical centers,” Dr. Nevins said in a May 13 news release.
The surgeons said they will use the Lynx Equity investment to seek FDA approval and expand the company’s intellectual property portfolio to prepare for global commercialization.
Terms of the investment were not disclosed.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
